Vanguard Group’s Aligos Therapeutics ALGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.68M | Buy |
|
|||||
|
2025
Q2 | $1.01M | Sell |
|
|||||
|
2025
Q1 | $1.16M | Buy |
|
|||||
|
2024
Q4 | $3.85M | Buy |
|
|||||
|
2024
Q3 | $553K | Hold |
|
|||||
|
2024
Q2 | $558K | Buy |
|
|||||
|
2024
Q1 | $993K | Buy |
|
|||||
|
2023
Q4 | $672K | Buy |
|
|||||
|
2023
Q3 | $755K | Buy |
|
|||||
|
2023
Q2 | $966K | Sell |
|
|||||
|
2023
Q1 | $889K | Buy |
|
|||||
|
2022
Q4 | $966K | Sell |
|
|||||
|
2022
Q3 | $1.2M | Buy |
|
|||||
|
2022
Q2 | $1.29M | Sell |
|
|||||
|
2022
Q1 | $2.76M | Sell |
|
|||||
|
2021
Q4 | $16.3M | Buy |
|
|||||
|
2021
Q3 | $19.8M | Buy |
|
|||||
|
2021
Q2 | $20M | Buy |
|
|||||
|
2021
Q1 | $14M | Buy |
|
|||||
|
2020
Q4 | $16.9M | Buy |
|